Breakthrough Innovation

Our proprietary platform represents the first AI-driven therapeutic optimization system specifically designed for Cytokine Release Syndrome management. By combining enhanced nanoformulated salsalate (Nanotrol™) with real-time biomarker analysis, we achieve unprecedented precision in CRS treatment.

The platform integrates machine learning algorithms that continuously analyze patient biomarkers including IL-6, IL-1β, TNF-α, and interferon-γ to optimize therapeutic selection and dosing in real-time, dramatically improving patient outcomes while reducing healthcare costs.

Our approach transforms CRS management from reactive treatment to proactive, personalized intervention, setting new standards for CAR-T therapy safety and efficacy.

10x Enhanced Bioavailability
85% Reduction in Severe CRS
60% Faster Recovery Time
$200M+ Patent Portfolio Value

Core Technology Components

Integrated platform combining AI optimization, enhanced formulations, and real-time analytics

Nanotrol™ Enhanced Formulation

Our proprietary nanoformulated salsalate represents a breakthrough in anti-inflammatory drug delivery. Through advanced nanotechnology, we've achieved 10x enhanced bioavailability compared to standard oral formulations, enabling effective intravenous administration for severe CRS cases where rapid intervention is critical.

Nanoparticle Engineering

Advanced lipid-based nanoparticles designed for optimal tissue penetration and cellular uptake

IV Administration

First-in-class IV formulation enabling rapid deployment in critical care settings

Enhanced Pharmacokinetics

Improved half-life and tissue distribution compared to conventional formulations

Safety Profile

Reduced systemic toxicity through targeted delivery and controlled release

AI-Driven Optimization Engine

Our machine learning platform analyzes real-time patient data to optimize therapeutic selection and dosing. The system processes multiple biomarker inputs, patient characteristics, and treatment responses to provide personalized recommendations that adapt as patient conditions evolve.

Machine Learning Models

Advanced neural networks trained on comprehensive CRS patient datasets

Real-Time Processing

Sub-second analysis and recommendation generation for critical care scenarios

Personalized Protocols

Individual patient optimization based on genetics, biomarkers, and response patterns

Continuous Learning

System improves with each patient interaction through federated learning networks

Real-Time Biomarker Monitoring

Comprehensive biomarker analysis platform that continuously monitors key inflammatory markers to guide treatment decisions. Our system tracks IL-6, IL-1β, TNF-α, interferon-γ, and other critical cytokines to detect CRS onset and monitor treatment response.

Multi-Cytokine Panels

Simultaneous monitoring of 15+ inflammatory biomarkers and cytokines

Point-of-Care Testing

Rapid bedside analysis with results available within 30 minutes

Predictive Analytics

Early warning systems to predict CRS severity before clinical symptoms appear

Data Integration

Seamless integration with hospital EHR systems and clinical workflows

Integrated Platform Architecture

Our comprehensive platform seamlessly integrates all components into a unified system that provides clinicians with actionable insights and automated treatment recommendations. The platform is designed for easy implementation in existing hospital infrastructure.

Cloud Architecture

Scalable, secure cloud infrastructure with 99.9% uptime guarantee

Mobile Interface

Physician mobile app for real-time alerts and treatment recommendations

HIPAA Compliance

Enterprise-grade security with full HIPAA compliance and data encryption

API Integration

RESTful APIs for seamless integration with existing hospital systems

Intellectual Property Portfolio

Comprehensive patent protection covering platform technology, formulations, and AI algorithms

Filed

AI-Driven Multi-Agent Therapeutic Optimization System

Core machine learning algorithms for real-time biomarker analysis and therapeutic selection optimization in CRS management.

US Patent Application Priority: 2025
Filed

Nanoformulated Salsalate Compositions

Proprietary nanoparticle formulations enabling IV administration of salsalate with enhanced bioavailability and reduced toxicity.

US Patent Application Priority: June 2018
Filed

Real-Time Biomarker Integration Methods

Systems and methods for continuous monitoring and integration of inflammatory biomarkers in clinical decision-making algorithms.

US Patent Application Priority: September 2025
Provisional

Predictive CRS Risk Stratification

Machine learning models for early prediction of CRS severity and treatment response optimization in CAR-T therapy patients.

US Provisional Priority: December 2025